Of all of the antigens tested, CD29 and CD98 were the most broadly expressed antigens among cancer cell lines, with CD98 having slightly higher expression than CD29 in MC38, B16, CT26, and Panc02 but almost equal expression in KPC (Figure 2, A and B). This evidence concerns the gene SLC3A2 and cancer.